Prostate Cancer - Results from #40

Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer. October 22, 2024

Comparison of Transatlantic Recommendations for Prostate Gland Evaluation with MRI after Focal Therapy (TARGET) and Prostate Imaging after Focal Ablation (PI-FAB) for Detecting Recurrent Prostate Cancer at Prostate MRI. October 22, 2024

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial. October 22, 2024

Optimizing risk stratification for intermediate-risk prostate cancer - the prognostic value of baseline health-related quality of life. October 22, 2024

Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate Cancer. October 22, 2024

Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers October 21, 2024

Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T October 21, 2024

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus. October 21, 2024

Simultaneous Autophagy and Androgen Receptor Inhibition in a Prostate Cancer Xenograft Model. October 21, 2024

Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: Initial Experience at a High-Volume Robotic Centre. October 21, 2024

Relugolix Plus Enzalutamide For Metastatic Hormone-Sensitive Prostate Cancer: A Case Report. October 21, 2024

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful. October 21, 2024

Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019. October 20, 2024

Diet Quality, Dietary Inflammatory Potential, and Risk of Prostate Cancer Grade Reclassification. October 20, 2024

Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review. October 18, 2024

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer-A pilot study. October 18, 2024

Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. October 18, 2024

Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers. October 18, 2024

Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. October 18, 2024

Aerobic Physical Activity and Depression Among Patients With Cancer A Systematic Review and Meta-Analysis October 17, 2024

Page 3 of 1434